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It is well known that asthma prevalence has been increasing all over the world in the last
decades. However, few data are available on temporal trends of incidence and remission of
asthma.
Objective
To evaluate the rates of asthma incidence and remission in Italy from 1940 to 2010.
Methods
The subjects were randomly sampled from the general Italian population between 1991 and
2010 in the three population-based multicentre studies: ECRHS, ISAYA, and GEIRD. Indi-
vidual information on the history of asthma (age at onset, age at the last attack, use of drugs
for asthma control, co-presence of hay-fever) was collected on 35,495 subjects aged 20–84
and born between 1925–1989. Temporal changes in rates of asthma incidence and remis-
sion in relation to age, birth cohort and calendar period (APC) were modelled using Poisson
regression and APCmodels.
Results
The average yearly rate of asthma incidence was 2.6/1000 (3,297 new cases among
1,263,885 person-years). The incidence rates have been linearly increasing, with a percent-
age increase of +3.9% (95%CI: 3.1–4.5), from 1940 up to the year 1995, when the rates
begun to level off. The stabilization of asthma incidence was mainly due to a decrease in the
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rates of atopic asthma after 1995, while non-atopic asthma has continued to increase. The
overall rate of remission was 43.2/1000person-years, and it did not vary significantly across
generations, but was associated with atopy, age at asthma onset and duration of the disease.
Conclusions
After 50 years of a continuous upward trend, the rates of asthma incidence underwent a
substantial stabilization in the late 90s. Despite remarkable improvements in the treatment
of asthma, the rate of remission did not change significantly in the last seventy years. Some
caveats are required in interpreting our results, given that our estimates are based on self-
reported events that could be affected by the recall bias.
Introduction
Many studies have shown that the prevalence of asthma has been rising all over the world since
the late 70’s [1]. Recent reports document that it is still increasing in many Westernized coun-
tries [2–5]. The causes of this epidemic are still not known. Furthermore, the specific temporal
trends in asthma incidence and remission have not been thoroughly investigated, due to the
few numbers of studies allowing the incidence to be estimated and their methodological
differences.
The study of the temporal variations in asthma incidence may help health-care providers
and decision makers to anticipate the burden of asthma and optimize clinical and public health
strategies. Furthermore, understanding whether these time trends are related to age, calendar
period or birth cohort might offer insights into the aetiology of the disease. In fact, temporal
trends may reflect variations in the distribution of the risk factors of asthma. According to
some authors, if the increase in environmental determinants is the cause of an epidemic, an
increased period effect (indicative of changes in risk factors that affect all ages equally) should
be expected. On the other hand, if perinatal exposure to some risk factors is the main cause of
the epidemic, a strong cohort effect should be present [6,7].
Finally, changes over time (independent of age) in the rates of remission of asthma may
reflect changes in the degree of severity of the disease, in the frequency of asthma under treat-
ment or improvements in available treatment options [8].
In this study we aimed to estimate:
• the effects of age, period and cohort on the incidence of asthma in Italy,
• the temporal variation in the rate of asthma remission during the period from 1940 to 2010.
Materials and Methods
Study design
This analysis studied 38,596 subjects, aged 20–84, born between 1925 and 1989, who were
recruited between 1991 and 2010 in the three population-based multicentre studies, using the
same design: the Italian arm of the European Community Respiratory Health Survey (ECRHS,
n = 6,031) [9], the Italian Study on Asthma in Young Adults (ISAYA, n = 18,873) [10], and the
Genes Environmental Interaction in Respiratory Diseases (GEIRD) study (n = 13,692) (S1
Text) [11]. In all the studies, a screening questionnaire enquiring about respiratory symptoms,
the past and present history of asthma, the presence of hay fever and the use of asthma drugs
was sent by post to each subject up to 3 times in the case of non-response. A telephone
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interview was administered to the remaining non- responders. The questionnaire used was
always the same [12], except in the case of the first ECRHS cross-sectional survey.
Ethics approval was obtained in each centre from the appropriate ethics committee. All par-
ticipants were fully informed about all aspects of the research project and consented to com-
plete and return the questionnaires.
Asthma incidence analysis and age-period-cohort analysis
Asthma Incidence. The presence of lifetime asthma and age at onset of asthma were iden-
tified on the basis of a positive answer (at baseline or during the follow-up) to the following
questions: “Have you ever had asthma?”; “How old were you when you had your first attack of
asthma?” [13].
Incidence rates were computed by dividing the number of events (asthma onset) by the total
number of person-years at risk. Person-years were defined as the time (in years) a subject was
at risk for development of asthma, i.e. the time from birth to the age of the first attack of
asthma, if the subject had asthma, or the time from birth until the date of the last interview, if
he/she did not have asthma. In the case of follow-up, age at onset of asthma was computed at
the time of the first reporting [14]. Atopic asthma was considered present if a subject reported
both asthma and allergic rhinitis (i.e. if a subject also replied affirmatively to the question “Do
you have any nasal allergies including hay fever?”)
Age-Period-Cohort (APC) models
Poisson regression models were used to test the effects of age, period and cohort (coded in
5-year intervals) on the incidence of asthma: five models were fitted to data: age; age–drift; age-
cohort; age-period; age–period–cohort. In these models, the term drift denotes a variable for
the overall linear time-trend, which cannot be attributed univocally to cohort or period effects,
while the period and cohort parameters are estimates of a non-linear effect [7,15]. The effects
of age, period and cohort were tested computing the change in deviance associated to suitable
models, according to usual principles of the generalized linear models theory [15]
The assessment of the age-period-cohort effects on asthma incidence were based on the fol-
lowing model:
logðlða; pÞÞ ¼ fpðaÞ þ dðpÞ þ gðpÞ þ hðcÞ
where λ refers to the asthma rates; f, g, and h are functions; a, p, and c refers to the age, period,
and cohort parameters, respectively; the drift parameter “δ” is set in the model to deal with the
intrinsic non-identiﬁability problem in APC analysis and to improve estimate interpretation.[7]
To report the three time-parameter effects in a sensible, understandable, and recognizable
way, the Carstensen’s restricted cubic spline method was fitted, using 5 knots for age, period
and cohort variables [7]. Period effects were calculated as rate ratios, relative to the reference
period (1975, which is half-way through the study), while cohort effects were constrained to be
null on average with null slope. Age-effects were shown as rates for the reference period. APC
models were estimated separately for males and females and for atopic and non-atopic asthma.
APC modeling was carried out using the apc.fit function in the Epi package in the R program
(version 3.0.2) [7].
Analysis of asthma remission
The analysis of asthma remission was limited to those subjects who had had asthma during
their lives. A subject was considered in remission if he/she had not had an asthma attack in the
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two years before the most recent interview and replied negatively to the following question:
“Are you currently taking any medicines (including inhalers, aerosols or tablets) for asthma?”.
The duration of the disease (time since onset) was computed as the time between the first and
the last asthma attack for subjects in remission, or as the time between the age at the first
asthma attack and the age at the last interview for current asthmatics.
Due to the low number of asthmatic subjects with remission, APC models were not used for
this analysis, but survival techniques were applied to the data, using the presence or absence of
remission as 'failure', and the time since the onset as 'time at risk'. A Poisson regression model
was used to assess the association of the remission of asthma with the potential prognostic fac-
tors (sex, age at onset, presence of hay-fever, birth cohort). The statistical analysis was per-
formed using STATA software, release 13.1.
Sensitivity Analyses
Three sensitivity analyses were performed to estimate the size of the potential bias due to retro-
spective approach and to potential differential recall on the incidence and remission of disease
[16]. Details are included in the supporting information (S2 Text).
Results
Participants and response rates
In total, 38,596 out of 57,769 eligible individuals (average response rate: 67%) took part in one
of the three surveys (ECRHS, ISAYA or GEIRD) and answered at least one of the relative
screening questionnaires. Of these, 2,144 subjects were excluded because they had only partici-
pated in the 1991–93 screening, which did not include the question about age at onset, and fur-
ther 987 subjects were excluded because they had some missing data on the main variables.
The analyses were carried on the remaining 35,495 subjects with complete information.
Rates of asthma incidence
Overall, 3,297 incident cases of asthma occurred among 1,263,885 person-years (py) (Table 1).
The average crude rate of asthma incidence was 2.6/1,000py. The subjects of the ECRHS survey
had lower rates of asthma incidence than those of the ISAYA and GEIRD surveys. The rate of
asthma incidence was 7-fold greater in subjects with allergic rhinitis than in subjects without.
Fig 1 summarizes the crude age-specific rates of asthma incidence, stratified by period of
asthma onset and by birth cohort. Children in the 0–9yrs age-group had the highest rates,
which steeply decreased until the age of 20–29yrs. For all the age-groups, the incidence rates of
asthma increased in recent years, and this trend was particularly evident in the case of younger
subjects. The age-specific rates of asthma were higher in more recent birth cohorts and periods
(person years, events and crude rates by age and cohort are reported in S1 Table).
Age-Period-Cohort “effects” on asthma incidence
The results of fitting Poisson regression models to the incidence data (Table 2), suggested that
the linear time trend (“drift”) was the most relevant determinant to explain the variation over
time of asthma incidence rates. Moreover, a statistically significant component related to
period emerged while there was no statistically significant effect due to the cohort (Fig 2).
APC effects were similar in men and women. Fig 3 shows the effects of age, period and
cohort on asthma incidence in males and females. The rates of asthma constantly increased
from 1940 up to 1995/2000, when the rates underwent a substantial stabilization, interrupting
the linear increase. Overall, the age-adjusted relative annual increase in asthma incidence rates
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during the period 1940–2010 was +3.9% (95%CI: 3.1–4.5), and this percentage increase was
almost identical in males (+4.0%, 95%CI: 3.3–4.7) and in females (+3.9%, 95%CI: 3.4–4.3).
Taken as a whole, the asthma incidence had a 10-fold increase in the last 70 years, and it dou-
bled between 1980 and 2000 (S3 Text).
In both genders, the rates of asthma incidence exponentially decreased from birth to the age
of 25, were almost stable from 25 to 45, and then decreased again after the age of 45. During
childhood, the rates of asthma incidence were higher in boys than girls, they were similar
Table 1. Person-years, number of subjects reporting ever having had asthma, and the crude incidence (95%CI) of asthma by sex, age at onset,
birth cohort, and period, type of study and presence of hay fever.
Person-years (py) No. of cases of asthma Incidence rates/1,000 py (95%CI)
Sex
women 646,577 1,618 2.5 (2.4–2.6)
men 617,309 1,679 2.7 (2.6–2.9)
Age at onset (y)
0–10 345,653 1,692 4.9 (4.7–5.1)
10–20 335,050 693 2.1 (1.9–2.2)
20–30 294,244 465 1.6 (1.4–1.7)
30–40 184,936 320 1.7 (1.6–1.9)
40–50 66,890 97 1.5 (1.2–1.8)
50–60 23,516 21 0.9 (0.6–1.4)
>60 13,596 9 0.7 (0.3–1.3)
Birth Cohort
1925–39 45,940 40 0.9 (0.6–1.2)
1940–9 85,907 99 1.2 (0.9–1.4)
1950–9 306,492 490 1.6 (1.5–1.7)
1960–9 493,129 1,272 2.6 (2.4–2.7)
1970–9 283,028 1,125 4 (3.7–4.2)
1980–9 49,390 271 5.5 (4.9–6.2)
Period
1925–39 4,106 2 0.5 (0.1–2.0)
1940–9 12,174 10 0.8 (0.4–1.5)
1950–9 50,485 92 1.8 (1.5–2.2)
1960–9 160,216 470 2.9 (2.7–3.2)
1970–9 283,859 882 3.1 (2.9–3.3)
1980–9 328,020 899 2.7 (2.6–2.9)
1990–9 305,755 673 2.2 (2.0–2.4)
2000–9 119,954 269 2.2 (2.0–2.5)
Survey
ECRHS 160,741 309 1.9 (1.7–2.1)
ISAYA 601,480 1,595 2.7 (2.5–2.8)
GEIRD 501,665 1,393 2.8 (2.6–2.9)
GEIRD – 20–44yrs 324,471 1,161 3.6 (3.4–3.7)
GEIRD – 45–64yrs 108,573 163 1.5 (1.3–1.8)
GEIRD – 65–84yrs 68,621 69 1.0 (0.8–1.3)
Hay fever
No 1,016,831 1,248 1.2 (1.2–1.3)
Yes 240,365 2,023 8.4 (8.1–8.8)
TOTAL 1,263,885 3,297 2.6 (2.5–2.7)
doi:10.1371/journal.pone.0138570.t001
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around puberty and then they became 30–50% lower in men than in women after the age of
20. (Fig 4)
The leveling-off of the continuous linear increase in asthma incidence, occurring in 1995/
2000, was mainly caused by the decrease in the incidence of asthma in allergic subjects (Table 2
and Fig 5). Indeed there was a strong and statistically significant period effect in allergic but
not in non-allergic subjects, meaning that the incidence of asthma no longer increased after
1995/2000 in allergic subjects, while it continued its linear upward trend in non-allergic
subjects.
Asthma remission
212 subjects with asthma were excluded from the remission analysis because of missing or
incongruent data at the questions on use of drugs for asthma or age at the last asthma attack.
Fifty-two percent of asthmatic subjects (1,610 out of 3,087) remitted. Subjects in remission had
Fig 1. Age-specific rates of asthma in Italy by period of asthma onset and birth cohort: A) Age-specific rates by year of onset: age at onset on x axis,
with rates corresponding to same period connected by lines; B) Age-specific rates by birth cohort: age at onset on x axis, with rates corresponding to same
cohorts connected by lines;C) Period-specific rates by age: year of onset on x axis, with rates corresponding to same age groups connected by lines;D)
Cohort-specific rates by age: year of birth on x axis, with rates corresponding to same age groups connected by lines.
doi:10.1371/journal.pone.0138570.g001
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an earlier mean age at onset (9.9yrs vs.19.4yrs, p<0.001) and a shorter duration of the disease
than subjects with current asthma (6.9yrs vs.17.7yrs, p<0.001). Overall, the rate of remission
was 43.2/1000py. The rates of remission were higher in men than in women, in more recent
generations, and in subjects without hay fever (Table 3). Furthermore, the rates of remission
were higher in people who developed asthma in childhood than in adulthood, and peaked in
the first years after the onset. When adjusting for all potential confounders, the variables that
Table 2. Comparison of age-period color sub-models for asthma rates in males and females and for atopic and non-atopic asthma in Italy.
Model Residual deviance (residual df) Effect Change in deviance (df) p-value
OVERALL
Age 403.63 (158) A
Age-drift(cohort) 217.32 (157) Δ†|A 186.31 (1) <0.0001
Age-Cohort 211.76 (153) C‡|A 5.56 (4) 0.235
Age-Period-Cohort 198.24 (149) P‡|A,C 13.53 (4) 0.009
Age-Period 201.09 (153) C‡|A,P -2.85 (-4) 0.583
Age-drift(period) 217.32 (157) P‡|A -16.23 (-4) 0.003
Males
Age 408.05 (158) A
Age-drift(cohort) 220.04 (157) Δ†|A 188.01 (1) <0.0001
Age-Cohort 214 (153) C‡|A 6.04 (4) 0.196
Age-Period-Cohort 200.69 (149) P‡|A,C 13.31 (4) 0.010
Age-Period 203.47 (153) C‡|A,P -2.78 (-4) 0.595
Age-drift(period) 220.04 (157) P‡|A -16.57 (-4) 0.002
Females
Age 385.2 (158) A
Age-drift(cohort) 218.42 (157) Δ†|A 166.78 (1) <0.0001
Age-Cohort 213.18 (153) C‡|A 5.25 (4) 0.263
Age-Period-Cohort 203.42 (149) P‡|A,C 9.76 (4) 0.045
Age-Period 208.2 (153) C‡|A,P -4.78 (-4) 0.310
Age-drift(period) 218.42 (157) P‡|A -10.22 (-4) 0.037
Atopic asthma
Age 540.85 (182) A
Age-drift(cohort) 287.02 (181) Δ†|A 253.832 (1) <0.0001
Age-Cohort 281.29 (177) C‡|A 5.728 (4) 0.220
Age-Period-Cohort 242.88 (173) P‡|A,C 38.411 (4) <0.0001
Age-Period 246.62 (177) C‡|A,P -3.736 (-4) 0.443
Age-drift(period) 287.02 (181) P‡|A -40.403 (-4) <0.0001
Non-atopic asthma
Age 337.09 (182) A
Age-drift(cohort) 221.9 (181) Δ†|A 115.195 (1) <0.0001
Age-Cohort 213.96 (177) C‡|A 7.935 (4) 0.093
Age-Period-Cohort 211.91 (173) P‡|A,C 2.05 (4) 0.727
Age-Period 221.05 (177) C‡|A,P -9.141 (-4) 0.058
Age-drift(period) 221.9 (181) P‡|A -0.845 (-4) 0.932
Age, period and birth cohorts are modelled in 5-years periods. A: age effect; P: period effect; C: cohort effect
† drift (linear) estimate
‡ curvature estimate
doi:10.1371/journal.pone.0138570.t002
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were statistically associated with the rate of remission were the presence of hay fever, the age at
onset and the time since onset of asthma. The rate of remission was stable across birth cohorts.
Sensitivity analyses
The sensitivity analyses (reported in the online repository) confirmed the main results, suggest-
ing that the recall bias and the retrospective approach might have affected our results only by a
minor extent.(S2 Text)
Discussion
The main results of the analyses on incidence and remission of asthma are:
• Asthma incidence steadily and continuously increased from 1940 to 1995, both in men and
women, with an average relative increase of 3.9% each year. This temporal trend cannot be
univocally attributed to period or cohort effects.
Fig 2. A-C. Estimated effects from the APCmodel for asthma incidence rates. Fig 2A represents the age-specific incidence rates, referred to the
reference period 1975; Fig 2B represents the merged period and drift effects (rate ratios): the linear increasing trend is given by the drift, while deviations from
linearity (curvature) are determined by the period effect; Fig 2C represents the birth cohort effect. The arrow in B indicates the calendar period when the
incidence of asthma has begun to level off. The respective regions surrounding the lines provide the 95% confidence intervals.
doi:10.1371/journal.pone.0138570.g002
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• Since 1995/2000 the incidence of asthma has levelled off. This “late period effect” was mainly
caused by the decrease of the incidence of atopic asthma, while the incidence of non-atopic
asthma is continuously increasing.
• After adjusting for period and cohort effects, the incidence of asthma showed a non-linear,
downward trend with ageing.
• The likelihood of asthma remission did not significantly vary across generations, despite
improvements in the treatment of the disease.
Trends in incidence of asthma over time
It has been suggested that the still increasing trend in the prevalence of asthma reported in
many countries might be attributable to an increase in the incidence of the disease [1–5].
However, little is known about the real temporal trend in the onset of asthma. The few
Fig 3. A-C. Estimated effects from the APCmodels for asthma incidence rates in males (blue tonalities) and females (red tonalities). Fig 3A
represents the age-specific incidence rates, referred to the reference period 1975; Fig 3B represents the merged period and drift effects (rate ratios), with
linear increasing trend determined by the drift, and deviations from linearity (curvature) determined by the period effect; Fig 3C represents the birth cohort
effect. The respective regions surrounding the lines provide the 95% confidence intervals (95%CI). Overlapping 95%CI are highlighted with lighter areas.
doi:10.1371/journal.pone.0138570.g003
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surveys that have estimated the incidence of asthma in different populations have shown that
incidence has tended to be higher in later studies, suggesting a rise in asthma incidence
[3,17,18].
This is one of the few studies that allowed the direct assessment of temporal trends in
asthma incidence in the last seventy years, thanks to the availability of different birth cohorts
from the same general Italian population, where the history of asthma was assessed at different
times with the same standardized methods. Our results document that the incidence of both
atopic and non-atopic asthma has increased almost linearly from 1940 to 1995/2000, with a rel-
ative annual increment of 3.9%. In the same period, a continuous increase in allergic sensitiza-
tion has been reported [19,20].
In our analysis, APC-models, which included both the drift (i.e., the linear variation of the
incidence in time that is not univocally attributable to a calendar-period or a cohort effect) and
the age, the period, and the cohort effects, were fitted to the data [7]. During the period 1940–
1995, the “drift” was the only statistically significant component. Accordingly, it was impossi-
ble to ascribe this increase to either a specific cohort or a calendar period effect. This suggests
that the rising incidence over time was due to an increased susceptibility that has affected all
Fig 4. Incidence rate ratios (RR, with 95%CI) of asthma by age in men vs. women.
doi:10.1371/journal.pone.0138570.g004
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age groups and generations since 1940. This pattern might reflect either increased population
exposures to widespread environmental determinants (allergens, pollutants, occupational
exposures) or lifestyles, such as those associated with increased levels of urbanization. At least
to a certain extent, this might also reflect an increased public and professional awareness of
asthma symptoms that has led to a larger diagnostic labeling of asthma in more recent decades.
The fact that the rising trend in incidence was the same for men and women documents that it
is not caused by gender-specific lifestyles or exposures.
The leveling off in asthma incidence after 1995/2000 seems to be driven by a “late period
effect” linked to a stabilization of incidence of atopic asthma, which represents the majority of
asthma cases, while the incidence of non-atopic asthma has continued to increase. This finding
agrees with a recent paper, which showed that non-atopic asthma was responsible for the
increase of asthma prevalence registered in the last decade in Italy [2].
Fig 5. A-C. Estimated effects from the APCmodels for incidence rates of atopic asthma (green tonalities) and non-atopic asthma (grey tonalities).
Fig 5A represents the age-specific incidence rates, referred to the reference period 1975; Fig 5B represents the merged period and drift effects (rate ratios),
with linear increasing trend determined by the drift, and deviations from linearity (curvature) determined by the period effect; Fig 5C represents the birth
cohort effect. The arrow in B indicates the calendar period when the incidence of asthma has begun to level off. The respective regions surrounding the lines
provide the 95% confidence intervals (95%CI). Overlapping 95%CI are highlighted with lighter areas.
doi:10.1371/journal.pone.0138570.g005
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The stabilization, or slight decrease, of the incidence of atopic asthma in the last ten years
might be due to a reduction in environmental exposures or to more effective “allergen avoid-
ance” strategies. However a potential alternative explanation could be that the “ceiling” level of
atopic asthma prevalence has been attained, meaning that the maximum effect of changing
environmental exposure in susceptible individuals has been already seen, and the proportion of
the population that has the potential of acquiring asthma has been reached [21].
It’s worth noting that non-atopic asthma has also been linked to smoking habits. However,
the incidence of non-atopic asthma is still increasing in Italy in spite of a decreasing trend in
smoking habits [22].
Incidence of asthma by sex and age
Our results in the age-sex-related pattern of incidence over the last seventy years, confirmed
what was observed in previous Italian and US studies using shorter calendar-time windows
[23,24]. Children, especially in an early age, experienced greater rates of incident asthma than
adults. Boys had higher rates of asthma than girls until puberty, while the reverse occurred in
adulthood. Moreover, our findings indicate that women continued to have a greater incidence
of asthma, even in their forties and fifties, at the onset of hormonal changes that characterize
menopause.
Our study also investigated the incidence of asthma among older subjects. In agreement
with WINER [24], we found that the incidence rates in both sexes decreased after the age of 40.
This downward trend parallels the decrease of allergic sensitization in older subjects and
Table 3. Number of subjects with asthma and asthma remissions, crude incidence and risk ratios (RR) of asthma remission adjusted by sex, pres-
ence of hay fever, age at onset, birth cohort, and time since onset.
Subjects Remissions Time at risk Remission rates Risk ratios
n n (%) Person-years per 1000 person-years (95% CI) adjusted RR (95%CI)
Sex
Men 1590 898 (56.5) 19778 45.4 (42.5–48.5) 1 (-)
Women 1497 712 (47.6) 17454 40.8 (37.9–43.9) 0.94 (0.85–1.04)
Hay fever
No 1165 769 (66.0) 10843 70.9 (66.1–76.1) 1 (-)
Yes 1898 825 (43.5) 26118 31.6 (29.5–33.8) 0.48 (0.43–0.53)
Birth cohort
before 1959 566 275 (48.6) 8400 32.7 (29.1–36.8) 1 (-)
1960–1969 1183 626 (52.9) 14905 42.0 (38.8–45.4) 1.08 (0.93–1.25)
after 1970 1338 709 (53.0) 13926 50.9 (47.3–54.8) 1.07 (0.92–1.25)
Age at onset (years)
0–14 1927 1256 (65.2) 26901 46.7 (44.2–49.3) 1 (-)
15–29 750 270 (36.0) 7512 35.9 (31.9–40.5) 0.73 (0.42–0.67)
30+ 410 84 (20.5) 2820 29.8 (24.1–36.9) 0.53 (0.41–0.53)
Time since the onset (years)
0–9 3087 1255 (41.7) 20749 60.5 (57.2–63.9) 1 (-)
10–19 1,358 272 (20.0) 9992 27.2 (24.2–30.7) 0.47 (0.19–0.31)
20–29 678 65 (9.6) 4502 14.4 (11.3–18.4) 0.24 (0.19–0.31)
30+ 266 18 (6.8) 1989 9.0 (5.7–14.3) 0.15 (0.09–0.21)
TOTAL 3087 1610 37232 43.2 (41.2–45.4)
CI: conﬁdence interval
doi:10.1371/journal.pone.0138570.t003
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replicates the natural history of other atopic diseases, such allergic rhinitis and eczema [25]. It
is worthwhile to mention that the decrease of asthma incidence after the age of 40 may partly
reflect the doctors’ differential propensity to diagnose asthma or COPD according to the age of
their patients [26]. Indeed, distinguishing between asthma and COPD can be quite challenging,
even for the most expert physician, and COPD is often misdiagnosed as asthma in young peo-
ple, while the opposite happens in the elderly [27].
Asthma remission
Despite the decreasing trend of incidence, the prevalence of asthma is still rising in Italy and in
many other countries [2,28]. This is because prevalence is a balance between incidence and
remission. The latter has to increase more quickly than the former in order to significantly
reverse the increasing trend of asthma in the last decades.
The average yearly rate of remission in Italy during the last seventy years was 43.2 per 1000
patients and did not significantly change over time (birth-cohorts). Remarkable improvements
in the treatment of asthma occurred in the same period: inhaled corticosteroids (ICS) were
introduced in the early 1970s and they became the first line therapy for patients with asthma
by the late 1980s [29].
Accordingly, our results document that despite these advances in therapy, which have con-
tributed to decline in asthma mortality [30], the remission of asthma has not significantly
improved in the last decades. This finding reflects either the fact that, up to now, asthma can-
not be cured but only controlled [31], and that patient variability in the severity and course of
the disease and poor patient adherence to therapy are historical barriers to reduce the burden
of asthma. Remission in asthma mainly occurs in patients with a mild form of the disease and
it is rarely observed among more severe subjects with poor lung function or a high level of
symptoms at baseline [32].
Furthermore, our results suggest that the baseline clinical characteristics of the patients are
the main determinants of prognosis of asthma. The rates of asthma remission were higher in
subjects who had developed asthma early in childhood and in those with a shorter duration of
the disease. The presence of allergic rhinitis, which was used as proxy of atopy, was a strong
marker of the persistence of asthma. These results are in agreement with previous studies,
which separately reported the rates of asthma remission in children and in adults [33–35].
Strengths and Limitations
This study used the data collected in three large, epidemiological, postal-screening surveys car-
ried out in Italy between 1991 and 2010. The response rate was quite high overall compared to
other similar multicenter studies on adults. The large number of person-years considered
(nearly 1.3million), and the variety of ages, periods and cohorts considered in the analyses are
the main strengths of this study.
The Italian centers involved in the study were not chosen randomly but on the basis of the
availability of research teams that were able to carry out the survey. However, the study areas
are spread all over Italy and well represent the geographical (North versus South, Sub-Conti-
nental versus Mediterranean) features of the country. Furthermore, in each center, the subjects
included in this study were randomly selected from the general population. The prevalence of
asthma obtained from the GEIRD study [2] is very similar to that obtained in a representative
national survey on adults, performed in the same period, using information from the Health
Search Database owned by the Italian College of General Practitioners [36], suggesting that the
results obtained in our sample are likely to be representative of the general population of Italian
adults. One limitation is that the history of asthma was self-reported by the subjects, and not
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confirmed by a clinical evaluation. However, the validity of the questions used in the surveys
had been tested in previous studies, showing good sensitivity and specificity [13,37], and this
definition has been adopted in several international studies [38].
Moreover, the information collected relies on the recall of the subjects. The estimates of
asthma incidence and remission are therefore potentially underestimated particularly in older
subjects, because elderly people who had an early onset and remission of the disease may more
frequently forget that they had asthma, than younger people with a more reliable recall. As a
consequence, this differential recall bias could have distorted the estimates of the time trends
and the assessment of the determinants of asthma incidence and remission. However, even if
we cannot completely exclude the presence of a possible recall bias, the sensitivity analyses per-
formed to assess the extent of the bias due to a possible differential recall in young and elderly
people suggest that the recall bias might have influenced the results of the main analyses only
to a minor extent. One more limitation is that atopy was not clinically assessed, but the pres-
ence of allergic rhinitis was considered a proxy of atopy in the subjects with asthma. However,
a recent publication by our group reported that 87% of subjects with both asthma and allergic
rhinitis had positive skin prick tests, while only 33% of subjects with asthma but not allergic
rhinitis had positive skin prick tests [39], indicating a discrete validity of the question on aller-
gic rhinitis in distinguishing allergic from non-allergic asthma.
Conclusions
After 50 years of a continuous upward trend, the rates of asthma incidence underwent a sub-
stantial stabilization in the mid-90s. The leveling off of the incidence was mainly due to the
decrease of the incidence of atopic asthma, while non-atopic asthma incidence has continued
to increase. Despite remarkable improvements in the treatment of asthma, the rate of remission
has not significantly changed in the last seventy years. Although the validity and the reliability
of the self reported history of asthma have been proved good, the recall bias might have influ-
enced our results to some extent. This potential source of error has to be taken into account
when interpreting our findings.
Supporting Information
S1 Table. Number of incident cases of asthma, person-years at risk, and incidence rates of
asthma (per 1,000 person-years) by age at onset and calendar period, modeled in 10-years
time intervals.
(DOCX)
S1 Text. Surveys included in the analyses.
(DOCX)
S2 Text. Sensitivity analyses.
(DOCX)
S3 Text. Estimates of age-period specific rates of asthma between 1940–2010.
(DOCX)
Author Contributions
Conceived and designed the experiments: RdM. Performed the experiments: RdM GVMEZ
SA. Analyzed the data: GP FL RdM. Contributed reagents/materials/analysis tools: RdM GV
ICMB PP. Wrote the paper: RdM GP. Critically reviewed the manuscript for important intel-
lectual content: AJ IC MB PP SA GV.
Seventy Years of Asthma
PLOSONE | DOI:10.1371/journal.pone.0138570 October 6, 2015 14 / 16
References
1. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006; 355(21):2226–2235. PMID:
17124020
2. de Marco R, Cappa V, Accordini S, Rava M, Antonicelli L, Bortolami O, et al. Trends in the prevalence
of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J 2012; 39(4):883–92. doi:
10.1183/09031936.00061611 PMID: 22005911
3. Gershon AS, Guan J, Wang C, To T. Trends in asthma prevalence and incidence in Ontario, Canada,
1996–2005: a population study. Am J Epidemiol 2010; 172(6):728–36. doi: 10.1093/aje/kwq189 PMID:
20716702
4. Zhang X, Morrison-Carpenter T, Holt JB, Callahan DB. Trends in adult current asthma prevalence and
contributing risk factors in the United States by state: 2000–2009. BMC Public Health 2013; 13:1156.
doi: 10.1186/1471-2458-13-1156 PMID: 24325173
5. Anandan C, Nurmatov U, van Schayck OCP, Sheikh A. Is the prevalence of asthma declining? System-
atic review of epidemiological studies. Allergy 2010; 65:152–67. doi: 10.1111/j.1398-9995.2009.
02244.x PMID: 19912154
6. Viel JF, Fournier E, Danzon A. Age-period-cohort modelling of non-Hodgkin's lymphoma incidence in a
French region: a period effect compatible with an environmental exposure. Environ Health 2010; 9:47.
doi: 10.1186/1476-069X-9-47 PMID: 20691115
7. Carstensen B. Age-period-cohort models for the Lexis diagram. Stat Med 2007; 26:3018–3045 PMID:
17177166
8. Rönmark E, Lindberg A, Watson L, Lundbäck B. Outcome and severity of adult onset asthma—report
from the obstructive lung disease in northern Sweden studies (OLIN). Respir Med 2007; 101(11):2370–
7. PMID: 17689949
9. Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey.
Eur Respir J 1994; 7:954–60. PMID: 8050554
10. de Marco R, Bugiani M, Cazzoletti L, Carosso A, Accordini S, Buriani O, et al. The control of asthma in
Italy. A multicentre descriptive study on young adults with doctor diagnosed current asthma. Allergy
2003; 58(3):221–8 PMID: 12653796
11. de Marco R, Accordini S, Antonicelli L, Bellia V, Bettin MD, Bombieri C, et al. The Gene-Environment
Interactions in Respiratory Diseases (GEIRD) Project. Int Arch Allergy Immunol 2010; 152:255–63. doi:
10.1159/000283034 PMID: 20150743
12. de Marco R, Zanolin ME, Accordini S, Signorelli D, Marinoni A, Bugiani M, et al. A new questionnaire for
the repeat of the first stage of the European Respiratory Health Survey. Eur Respir J 1999; 14(5):1044–
8. PMID: 10596688
13. Pattaro C, Locatelli F, Sunyer J, de Marco R. Using the age at onset may increase the reliability of longi-
tudinal asthma assessment. J Clin Epidemiol. 2007; 60(7):704–11. PMID: 17573986
14. de Marco R, Locatelli F, Cerveri I, Bugiani M, Marinoni A, Giammarco G, et al. Incidence and remission
of asthma: A retrospective study on the natural history of asthma in Italy. J Allergy Clin Immunol 2002;
110:227–34.
15. Clayton D; Schifflers E. Models for temporal variation in cancer rates. II: Age-period-cohort models.
Stat Med 1987; 6:449–67. PMID: 3629047
16. Brogger J, Eagan T, Eide GE, Bakke P, Gulsvik A. Bias in retrospective studies of trends in asthma inci-
dence. Eur Respir J 2004; 23(2):281–6. PMID: 14979504
17. Eagan TM, Brøgger JC, Eide GE, Bakke PS. The incidence of adult asthma: a review. Int J Tuberc
Lung Dis 2005; 9(6):603–612. PMID: 15971386
18. Rudd RA, Moorman JE. Asthma incidence: data from the National Health Interview Survey, 1980–
1996. J Asthma 2007; 44(1):65–70. PMID: 17365207
19. Jarvis D, Luczynska C, Chinn S, Potts J, Sunyer J, Janson C, et al. Change in prevalence of IgE sensiti-
zation and mean total IgE with age and cohort. J Allergy Clin Immunol 2005; 116(3):675–82. PMID:
16159642
20. Law M, Morris JK, Wald N, Luczynska C, Burney P. Changes in atopy over a quarter of a century,
based on cross sectional data at three time periods. BMJ 2005; 330(7501):1187–8 PMID: 15833748
21. Nowak D, Suppli Ulrik C, von Mutius E. Asthma and atopy: has peak prevalence been reached? Eur
Respir J 2004; 23:359–360. PMID: 15065820
22. Verlato G, Accordini S, Nguyen G, Marchetti P, Cazzoletti L, Ferrari M, et al. Socioeconomic inequali-
ties in smoking habits are still increasing in Italy. BMC Public Health 2014; 14:879 doi: 10.1186/1471-
2458-14-879 PMID: 25159912
Seventy Years of Asthma
PLOSONE | DOI:10.1371/journal.pone.0138570 October 6, 2015 15 / 16
23. de Marco R, Locatelli F, Sunyer J, Burney P. Differences in incidence of reported asthma related to age
in men and women. A retrospective analysis of the data of the European Community Respiratory Health
Survey. Am J Respir Crit Care Med 2000; 162:68–74. PMID: 10903222
24. Winer RA, Qin X, Harrington T, Moorman J, Zahran H. Asthma incidence among children and adults:
findings from the Behavioral Risk Factor Surveillance system asthma call-back survey—United States,
2006–2008. J Asthma. 2012; 49:16–22. doi: 10.3109/02770903.2011.637594 PMID: 22236442
25. Warm K, Backman H, Lindberg A, Lundbäck B, Rönmark E. Low incidence and high remission of aller-
gic sensitization among adults. J Allergy Clin Immunol. 2012; 129:136–42. doi: 10.1016/j.jaci.2011.08.
033 PMID: 21975174
26. de Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, et al. The coexistence of asthma
and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged
and elderly people from the general population. PLoS One 2013; 8(5):e62985. doi: 10.1371/journal.
pone.0062985 PMID: 23675448
27. Miravitlles M, Andreu I, Romero Y, Sitjar S, Altés A, Anton E. Difficulties in differential diagnosis of
COPD and asthma in primary care. Br J Gen Pract 2012; 62(595):e68–75 doi: 10.3399/bjgp12X625111
PMID: 22520766
28. To T, Stanojevic S, Feldman R, Moineddin R, Atenafu EG, Guan J, Gershon AS. Is asthma a vanishing
disease? A study to forecast the burden of asthma in 2022. BMC Public Health 2013; 13:254. doi: 10.
1186/1471-2458-13-254 PMID: 23517452
29. Berger W. New approaches to managing asthma: a US perspective. Ther Clin Risk Manag 2008; 4
(2):363–79. PMID: 18728834
30. Suissa S, Ernst P. Benayoun S, Baltzan M, Cai B. Low dose inhaled corticosteroids and the prevention
of death from asthma. N Engl J Med 2000: 343:332–6. PMID: 10922423
31. Greening AP, Stempel D,Bateman ED, Vircow JC. Managing asthma patients: which outcomes matter?
Eur Respir Rev 2008: 17:53–61.
32. de Marco R, Marcon A, Jarvis D, Accordini S, Almar E, Bugiani M, et al. Prognostic factors of asthma
severity: a 9-year international prospective cohort study. J Allergy Clin Immunol 2006; 117(6):1249–56
PMID: 16750983
33. Andersson M, Hedman L, Bjerg A, Forsberg B, Lundbäck B, Rönmark E. Remission and persistence of
asthma followed from 7 to 19 years of age. Pediatrics 2013; 132:e435–42. doi: 10.1542/peds.2013-
0741 PMID: 23897917
34. Holm M, Omenaas E, Gislason T, Svanes C, Jögi R, Norrman E, et al. Remission of asthma: a prospec-
tive longitudinal study from northern Europe (RHINE study). Eur Respir J 2007; 30:62–65. PMID:
17360725
35. Tai A, Tran H, Roberts M, Clarke N, Gibson AM, Vidmar S, et al. Outcomes of childhood asthma to the
age of 50 years. J Allergy Clin Immunol 2014; 133: 1572–8. doi: 10.1016/j.jaci.2013.12.1033 PMID:
24495434
36. Cazzola M, Puxeddu E, Bettoncelli G, Novelli L, Segreti A, Cricelli C, Calzetta L. The prevalence of
asthma and COPD in Italy: a practice-based study. Respir Med 2011; 105(3):386–91. doi: 10.1016/j.
rmed.2010.09.022 PMID: 20951017
37. de Marco R, Cerveri I, Bugiani M, Ferrari M, Verlato G. An undetected burden of asthma in Italy: the
relationship between clinical and epidemiological diagnosis of asthma. Eur Respir J 1998; 11(3):5999–
605
38. Anto JM, Sunyer J, Basagana X, Garcia-Esteban R, Cerveri I, de Marco R, et al. Risk factors of new-
onset asthma in adults: a population-based international cohort study. Allergy 2010; 65(8):1021–30 doi:
10.1111/j.1398-9995.2009.02301.x PMID: 20132157
39. Ferrari M, Pesce G, Marcon A, Vallerio P, Fratta Pasini AM, de Marco R.Rhinitis is associated with a
greater risk of intermittent claudication in adults. Allergy 2014; 69(4):472–8. doi: 10.1111/all.12354
PMID: 24446919
Seventy Years of Asthma
PLOSONE | DOI:10.1371/journal.pone.0138570 October 6, 2015 16 / 16
